AzTrials
AzTrials

Cognitive AgingEarly Phase 1PEACHNCT04922710

Physical Exercise for Augmenting Cognitive Health (PEACH)

A Early Phase 1 study testing Home-based aerobic exercise in people with Cognitive Aging and Adverse Childhood Experiences, run by University of Pittsburgh at 2 sites in 2 countries.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

PEACH is a pilot project which is being conducted to determine the feasibility and acceptability of a 12-week home-based exercise intervention among Black and African American adults. A secondary aim of the project is to determine whether the exercise intervention improves cognitive and psychological functioning. Read more about this study

Who is it for?
Ages 30 to 55 yearsHealthy volunteers can take part
What is being tested?
Home-based aerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
2 sitesin 2 countries
Study dates
4 Jan 2022to 30 May 2023
Phase
Early Phase 1
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • adults aged 30-55 years
  • exposure to at least one form of threat-related adversity (e.g., exposure to violence; physical abuse) occurring prior to age 10 as documented by retrospective self-report
  • Self-identified Black or African American Race
  • access to high-speed internet
  • sedentary lifestyle (<60 minutes of PA/week).
  • no difficulties with mobility
Show all 9Show fewer
  • Does not currently require the use of an assisted walking device
  • Does not have a history of balance difficulties
  • Not currently pregnant or planning to become pregnant in the next 12 months

Who cannot join

  • Psychosis
  • Significant suicide risk (i.e., current, active suicidal ideation with a plan)
  • Engaging in moderate-intensity exercise >=20 min per day, >=3 times per week
  • Current treatment for cancer
  • Neurological condition (MS, Parkinson's, Dementia, MCI) or brain injury (Stroke)
  • Substance use disorder in the past 3-months
Show all 15Show fewer
  • Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep vein thrombosis (DVT) or other cardiovascular event
  • Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac condition in the past year
  • Sensory Impairment that would preclude neuropsychological testing
  • Not fluent in English
  • Travelling consecutively for 2+ weeks during the study
  • uncontrolled hypertension
  • Insulin-Dependent Diabetes Mellitus
  • Self-identified race anything other than Black or African American
  • Currently pregnant or planning to become pregnant in the next 12 months

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • Sennott Square

    Pittsburgh, Pennsylvania, 15220-2505

Other trials in United States

Jamaica1 site
  • University of the West Indies

    Kingston

Other trials in Jamaica

About this study

Official title: Physical Exercise for Augmenting Cognitive Health

PEACH is a pilot project which is being conducted to determine the feasibility and acceptability of a 12-week home-based exercise intervention among Black and African American adults. A secondary aim of the project is to determine whether the exercise intervention improves cognitive and psychological functioning.

Read the detailed description

This pilot project aims to address the impact of early life adversity (ELA) on brain health in adulthood by conducting a pilot 12-week physical activity (PA) intervention delivered remotely using aerobic exercise bikes programmed to connect users with a trainer via an app. Investigators will recruit Black and African American individuals between the ages of 30-55 years (N = 40) who are currently sedentary and report experiencing at least one form of ELA prior to the age of 10. This study will be conducted at two sites: the University of Pittsburgh in Pittsburgh, PA, USA and the University of the West Indies in Kingston, Jamaica (site investigator: Terrence Forrester). At baseline and following the 12-week intervention, Investigators will collect a harmonized battery of cognitive, behavioral and psychosocial measures. The intervention itself will be home-based and will involve three 60-minute sessions of aerobic exercise per week using a Bluetooth-enable exercise bike. Participants' exercise programs will be supervised remotely by an exercise trainer and individualized depending on their age-adjusted heart rate reserve, with the goal being to have participants reach 50 minutes of moderate to vigorous intensity exercise per session by the end of the first 4 weeks of the intervention. The bikes will be outfitted with a tablet featuring an application called Neotiv. The Neotiv application will collect data from the bike regarding timing, duration, and intensity of exercise sessions, which will be securely shared with the exercise trainer to monitor attendance and adherence. The primary goals of this study are to determine whether the home-based exercise program (1) is feasible and acceptable (as measured by adherence and attendance), and (2) promotes improvements in cognitive and psychological functioning among adults who have been exposed to ELA, contingent on the feasibility. We realized that placing the health-related outcomes as primary or secondary outcomes would only make sense if the approach was feasible. Therefore, we revised the primary and secondary outcome measures to reflect the feasibility of the home-based exercise intervention program in terms of adherence and attendance.

Being tested
Home-based aerobic exercise
Keywords
Adverse Childhood Experiences, Brain Health, Cognitive Aging, Exercise, Reversibility Network
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Home-based aerobic exerciseBehavioural

    Guidelines for exercise programming (ACSM, 2018) will be followed including a warmup and cool down, progressive and gradual increments in duration, and instruction regarding avoidance of physical activity related injury. The exercise group will receive moderate to vigorous intensity aerobic exercise for 60 minutes per day, three times a week, for 12 weeks. Participants who are unable to do a 60-minute session would instead complete it in two 30-minute sessions. The prescribed intensity will be based on estimated heart rate reserve, calculated using resting heart rate and age-adjusted heart rate maximum (220-age in years). Participants will maintain a minimum heart rate from their specific calculation that will be monitored by Polar Heart Rate straps.

Study groups in NCT04922710
Study groupRoleWhat they receive
Home-based aerobic exerciseExperimentalUn-supervised exercise will be held 3 times a week for 60 minutes in the participant's home. Those who are unable to do a 60-minute session would instead complete it in two 30-minute sessions to reach the goal of exercising 150 minutes per week.
Receives: Behavioral: Home-based aerobic exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adherence to Exercise Intervention Program: Average Minutes Spent in Moderate to Vigorous Exercise

    Data regarding the average number of minutes spent engaging in moderate to vigorous exercise (via heart rate monitoring and comparison of heart rate to calculations based on heart rate reserve) will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.

    Measured: baseline to 12 weeks

Secondary outcomes (1)
  1. Adherence to Exercise Intervention Program: Number of Sessions Completed

    Data regarding the number of exercise sessions completed will be collected to operationalize adherence. Adherence will be used as a metric of feasibility and acceptability.

    Measured: baseline to 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2021
  2. Study start4 Jan 2022
  3. Primary completion3 May 2023
  4. Study completion30 May 2023

Why it stopped: The study protocol was not feasible. We made several modifications but halted the study prematurely before we met our target sample size goal.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
A single group assigned a remote exercise intervention
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04922710
Sponsor's protocol ID
STUDY20120192
Other IDs
R24AG065174-01
Acronym
PEACH
Status last verified
May 2024
First submitted
8 Jun 2021
Last updated
6 Jun 2024
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data from this study will be made available to outside investigators under a data-sharing agreement. The data will be available to outside investigators after publication of the primary aims and at completion of quality control assessments and data organization. The investigators expect that the data from this study will result in interest from internal and external investigators for secondary analysis and ancillary projects.

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing Home-based aerobic exercise in people with Cognitive Aging and Adverse Childhood Experiences, run by University of Pittsburgh at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Jamaica. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 6 Jun 2024). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adherence to Exercise Intervention Program: Average Minutes Spent in Moderate to Vigorous Exercise (time frame: baseline to 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2024.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in